homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

May 29, 2020

Nautilus Biotechnology

Nautilus Biotechnology raised $76 million in Series B financing in a round led by Vulcan Capital, the investment arm of the late Paul Allen's Vulcan Inc. Other investors were Perceptive Advisors, Bezos Expeditions, Defy Partners, AME Cloud Ventures, Andreessen Horowitz, Bolt, and Madrona Venture Group. The money will be used to hire scientific and engineering staff across a variety of levels and disciplines. Nautilus is working to quantify the human proteome with higher precision and lower cost to speed development of therapeutic medicines. It is based in Seattle and San Carlos, California.




Email or user name:
Password:
 
Forgot password? Click here.